Trade COGT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cogent Biosciences, Inc. (COGT) is trading at US$31.50, down 5.09% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$6.37B. Over the past 52 weeks, COGT has traded between US$11.60 and US$43.73. On Syfe you can trade COGT with $0 commission and add it to your watchlist.
| Previous close | US$33.19 |
|---|---|
| Market cap | US$6.37B |
| 52-week range | US$11.60 – US$43.73 |
| Volume | 4.6M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
Year: 2018
Cogent Biosciences Q2 Loss Widens
Aug 10, 12:37 PM · MT Newswires
--Earnings Flash (COGT) Cogent Biosciences Posts Q2 Net Loss $96.4M, vs. FactSet Est of $98M Loss
Aug 10, 12:20 PM · MT Newswires
Cogent Biosciences, Inc. (COGT) stock is trading at US$31.50, -5.09% from the previous close of US$33.19.
The market cap for Cogent Biosciences, Inc. (COGT) stock is approximately US$6.37B.
The 52-week high for Cogent Biosciences, Inc. (COGT) stock is US$43.73.
The 52-week low for Cogent Biosciences, Inc. (COGT) stock is US$11.60.
Cogent Biosciences, Inc. (COGT) does not currently pay a dividend.
Stay on top of COGT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
